Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
一项针对住院重症SARS-CoV-2感染患者的二期随机研究，比较氯喹、羟氯喹或伊维菌素的疗效。
期刊:Pathogens and Global Health
影响因子:2.5
doi:10.1080/20477724.2021.1890887
Galan, Luis Enrique Bermejo; Santos, Nayara Melo Dos; Asato, Mauro Shosuka; Araújo, Jucineide Vieira; de Lima Moreira, Adriana; Araújo, Aléxia Mahara Marques; Paiva, Artur Diogenes Pinheiro; Portella, Diego Guilherme Santos; Marques, Frank Silas Saldanha; Silva, Gabriel Melo Alexandre; de Sousa Resende, Joana; Tizolim, Marycassiely Rodrigues; Santos, Poliana Lucenados; Buttenbender, Steffi Ferreira; de Andrade, Stephanye Batista; Carbonell, Roberto Carlos Cruz; Da Rocha, Juliana Gomes; de Souza, Ruy Guilherme Silveira; da Fonseca, Allex Jardim
